Citation Impact

Citing Papers

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
Parenteral Anticoagulants
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry Crossmatches
2007
Long‐term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High‐Fat Diet‐fed KK/HlJ Mice
2009
mTOR Signaling in Growth Control and Disease
2012 Standout
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis
2011
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
2006
Rapamycin: One Drug, Many Effects
2014 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Aspergillosis in Solid Organ Transplantation
2013
24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
2010
Hypercoagulability in Renal Transplant Recipients
2004
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Invasive fungal infections in solid organ transplant recipients
2014
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
2007
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells
2005
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Prevention of Venous Thromboembolism
2004 Standout
Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
2009
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Prevention of Venous Thromboembolism
2008 Standout
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma
2006
Combined Effects of Losartan and Pravastatin on Interstitial Inflammation and Fibrosis in Chronic Cyclosporine-Induced Nephropathy
2005
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians
2010
Cannabinoids and the gut: New developments and emerging concepts
2010
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
2008
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients
2015
Physiology and Pathophysiology of Carnosine
2013 Standout
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
2014
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
2006
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Multicenter evaluation of efficacy and safety of low‐dose versus high‐dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
2016
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Fish oil for kidney transplant recipients
2016

Works of A. Scott Mathis being referenced

HYPERCOAGULABLE STATES IN RENAL TRANSPLANT CANDIDATES: IMPACT OF ANTICOAGULATION UPON INCIDENCE OF RENAL ALLOGRAFT THROMBOSIS
2001
Prescribing Patterns and Outcomes of Enoxaparin for Anticoagulation of Atrial Fibrillation
2003
Probable Case of Torsades de Pointes Induced by Fluconazole
2002
Expression of PPAR, RXR Isoforms and Fatty Acid Transporting Proteins in the Rat and Human Gastrointestinal Tracts
2004
Combined use of sirolimus and voriconazole in renal transplantation: A report of two cases
2004
Oral Ganciclovir Versus Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Recipients of Kidney and Pancreas Transplants
2007
SEX AND ETHNICITY MAY CHIEFLY INFLUENCE THE INTERACTION OF FLUCONAZOLE WITH CALCINEURIN INHIBITORS12
2001
Drug-related dyslipidemia after renal transplantation
2004
Rankless by CCL
2026